在监狱中关押人群中消除丙型肝炎：在卫生系统框架内采取行动的挑战和建议。
Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.
机构信息
Department of Medicine, Divisions of General Internal Medicine and Infectious Disease, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, NY, USA.
Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University, Montreal, QC, Canada; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
出版信息
Lancet Gastroenterol Hepatol. 2021 May;6(5):391-400. doi: 10.1016/S2468-1253(20)30365-4.
Abstract
Hepatitis C virus (HCV) is a global public health problem in correctional settings. The International Network on Health and Hepatitis in Substance Users-Prisons Network is a special interest group committed to advancing scientific knowledge exchange and advocacy for HCV prevention and care in correctional settings. In this Review, we highlight seven priority areas and best practices for improving HCV care in correctional settings: changing political will, ensuring access to HCV diagnosis and testing, promoting optimal models of HCV care and treatment, improving surveillance and monitoring of the HCV care cascade, reducing stigma and tackling the social determinants of health inequalities, implementing HCV prevention and harm reduction programmes, and advancing prison-based research.
摘要
丙型肝炎病毒（HCV）是监管场所的全球性公共卫生问题。国际药物使用与健康网络-囚犯网络是一个特别利益集团，致力于推进科学知识交流，并倡导在监管场所预防和治疗 HCV。在这篇综述中，我们强调了改善监管场所 HCV 护理的七个优先领域和最佳实践：改变政治意愿，确保 HCV 诊断和检测的可及性，促进 HCV 护理和治疗的最佳模式，改善 HCV 护理级联的监测和监测，减少污名化和解决健康不平等的社会决定因素，实施 HCV 预防和减少伤害方案，以及推进监狱内的研究。
相似文献
1
Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework.在监狱中关押人群中消除丙型肝炎：在卫生系统框架内采取行动的挑战和建议。
Lancet Gastroenterol Hepatol. 2021 May;6(5):391-400. doi: 10.1016/S2468-1253(20)30365-4.
2
Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.监狱丙型肝炎服务的障碍与宣传需求：为监狱丙型肝炎宣传工具包提供信息
Int J Drug Policy. 2024 Apr;126:104386. doi: 10.1016/j.drugpo.2024.104386. Epub 2024 Mar 15.
3
Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.如何让研究人员、从业者、政策制定者和受影响的社区共同努力，改善吸毒人群获得丙型肝炎治疗的途径，为这些人群确定优先事项和推荐行动。
Int J Drug Policy. 2019 Apr;66:87-93. doi: 10.1016/j.drugpo.2019.01.012. Epub 2019 Feb 8.
4
A framework for management of hepatitis C in prisons.监狱中丙型肝炎管理框架。
Ann Intern Med. 2006 May 16;144(10):762-9. doi: 10.7326/0003-4819-144-10-200605160-00010.
5
The furthest left behind: the urgent need to scale up harm reduction in prisons.最被忽视的：监狱中扩大减少伤害措施的迫切需求。
Int J Prison Health. 2017 Sep 11;13(3-4):185-191. doi: 10.1108/IJPH-08-2016-0044.
6
Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.评估一所监狱外展诊所对丙型肝炎的诊断和预防工作：对国家战略的启示
Gut. 2003 Oct;52(10):1500-4. doi: 10.1136/gut.52.10.1500.
7
Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).考虑在澳大利亚监狱扩大治疗即预防措施：澳大利亚“监测和治疗丙型肝炎囚犯”项目（SToP-C）专家利益相关者的定性子研究。
Harm Reduct J. 2021 Apr 26;18(1):46. doi: 10.1186/s12954-021-00494-4.
8
"You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.“你需要一名指定官员”——惩教和司法卫生人员关于在监狱环境中扩大丙型肝炎治疗即预防的建议。
Int J Drug Policy. 2022 Aug;106:103746. doi: 10.1016/j.drugpo.2022.103746. Epub 2022 May 27.
9
Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.减少危害和欧洲监狱中的丙型肝炎病毒：25 个国家的横断面调查。
Harm Reduct J. 2018 May 11;15(1):25. doi: 10.1186/s12954-018-0230-1.
10
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.整合多种针对注射吸毒者丙型肝炎预防和护理的项目及政策方法：一种综合方法。
Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20.
引用本文的文献
1
Hepatitis C Testing Protocols Across Massachusetts Jails, 2022-2023: An Opportunity for Intervention.2022 - 2023年马萨诸塞州各监狱的丙型肝炎检测方案：干预的契机
Public Health Rep. 2025 Jun 16:333549251325067. doi: 10.1177/00333549251325067.
2
3
Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection.德国注射吸毒者中丙型肝炎消除工作的进展与挑战：首次数据收集10年后一项国家监测系统试点研究的结果
Harm Reduct J. 2024 Dec 20;21(1):222. doi: 10.1186/s12954-024-01119-2.
4
Implementation of Project ECHO in a university health network: contrasting and comparing experiences across health conditions through a qualitative approach in a Canadian tertiary care centre.在大学健康网络中实施 ECHO 项目：通过加拿大三级保健中心的定性方法比较和对比不同健康状况下的经验。
BMJ Open. 2024 Sep 17;14(9):e082947. doi: 10.1136/bmjopen-2023-082947.
5
Impact of the COVID-19 pandemic on hepatitis C virus screening in provincial prisons in Montreal, Quebec, Canada.加拿大魁北克省蒙特利尔省监狱内 COVID-19 大流行对丙型肝炎病毒筛查的影响。
Front Public Health. 2024 Jul 23;12:1380126. doi: 10.3389/fpubh.2024.1380126. eCollection 2024.
6
"If everyone knew about this, how many lives could we save?": Do drug suppliers have a role in reducing overdose risk?“要是每个人都知道这事，我们能挽救多少生命？”：药品供应商在降低用药过量风险方面能发挥作用吗？
Drug Alcohol Depend Rep. 2024 Jun 24;12:100250. doi: 10.1016/j.dadr.2024.100250. eCollection 2024 Sep.
7
Mental and physical health morbidity among people in prisons: an umbrella review.监狱人群的精神和身体健康发病率：伞式综述。
Lancet Public Health. 2024 Apr;9(4):e250-e260. doi: 10.1016/S2468-2667(24)00023-9.
8
The Efficacy of On-Site Integration Screening and Microelimination Programs for Chronic Hepatitis C in a Detection Center: A Comparison of the Treatment Outcomes and Characteristics of Incarcerated Patients and Outpatients.某检测中心慢性丙型肝炎现场综合筛查及微消除项目的疗效：监禁患者与门诊患者治疗结果及特征的比较
Int J Hepatol. 2024 Mar 13;2024:3184892. doi: 10.1155/2024/3184892. eCollection 2024.
9
Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.监狱丙型肝炎服务的障碍与宣传需求：为监狱丙型肝炎宣传工具包提供信息
Int J Drug Policy. 2024 Apr;126:104386. doi: 10.1016/j.drugpo.2024.104386. Epub 2024 Mar 15.
10
Retrospective review of rates of sexually transmitted and blood-borne infection (STBBI) testing in provincial corrections facilities in Newfoundland and Labrador.对纽芬兰和拉布拉多省惩教设施中性传播和血源感染（STBBI）检测率的回顾性研究。
J Assoc Med Microbiol Infect Dis Can. 2023 Sep 18;8(2):141-149. doi: 10.3138/jammi-2022-0036. eCollection 2023 Sep.
本文引用的文献
1
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.澳大利亚监狱内丙型肝炎治疗即预防的评估（SToP-C）：一项前瞻性队列研究。
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):533-546. doi: 10.1016/S2468-1253(21)00077-7. Epub 2021 May 7.
2
Knowledge, attitudes, and acceptability of direct-acting antiviral hepatitis C treatment among people incarcerated in jail: A qualitative study.在押囚犯对直接作用抗病毒丙型肝炎治疗的认知、态度和可接受性：一项定性研究。
PLoS One. 2020 Dec 2;15(12):e0242623. doi: 10.1371/journal.pone.0242623. eCollection 2020.
3
A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada.一项在加拿大蒙特利尔的男性囚犯中评估即时 HCV 检测可接受性的随机试点研究。
Int J Drug Policy. 2020 Nov;85:102921. doi: 10.1016/j.drugpo.2020.102921. Epub 2020 Sep 7.
4
The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic Review.药物治疗阿片类药物使用障碍对监禁人群丙型肝炎发病率的影响：系统评价。
Infect Dis Clin North Am. 2020 Sep;34(3):559-584. doi: 10.1016/j.idc.2020.06.011.
5
Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study.直接准入转诊的床边丙型肝炎筛查提高中途之家居民的护理衔接：一项试点随机研究。
Singapore Med J. 2022 Feb;63(2):86-92. doi: 10.11622/smedj.2020116. Epub 2020 Jul 30.
6
The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection.美国及全球丙型肝炎病毒感染直接抗病毒治疗方案的可及现状
Clin Liver Dis (Hoboken). 2020 Jul 21;16(1):16-19. doi: 10.1002/cld.925. eCollection 2020 Jul.
7
Hepatitis C reflex testing in Spain in 2019: A story of success.2019年西班牙丙型肝炎反射检测：成功的故事。
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Mar;39(3):119-126. doi: 10.1016/j.eimc.2020.03.004. Epub 2020 May 22.
8
Prisoners should not be left behind in HCV research and policies.在 HCV 研究和政策中，不应忽视囚犯这一群体。
Harm Reduct J. 2020 May 24;17(1):33. doi: 10.1186/s12954-020-00379-y.
9
The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada.加拿大蒙特利尔基于监狱的干预措施在减少注射吸毒人群中丙型肝炎病毒（HCV）传播中的作用。
Int J Drug Policy. 2021 Feb;88:102738. doi: 10.1016/j.drugpo.2020.102738. Epub 2020 Apr 8.
10
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新：美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
Zotero 插件